Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 31
Filter
2.
BMC Infect Dis ; 11: 220, 2011 Aug 17.
Article in English | MEDLINE | ID: mdl-21849074

ABSTRACT

BACKGROUND: Infections of the central nervous system (CNS) with herpes- or enterovirus can be self-limiting and benign, but occasionally result in severe and fatal disease. The polymerase chain reaction (PCR) has revolutionized the diagnostics of viral pathogens, and by multiple displacement amplification (MDA) prior to real-time PCR the sensitivity might be further enhanced. The aim of this study was to investigate if herpes- or enterovirus can be detected in cerebrospinal fluid (CSF) from patients without symptoms. METHODS: Cerebrospinal fluid (CSF) samples from 373 patients lacking typical symptoms of viral CNS infection were analysed by real-time PCR targeting herpesviruses or enteroviruses with or without prior MDA. RESULTS: In total, virus was detected in 17 patients (4%). Epstein-Barr virus (EBV) was most commonly detected, in general from patients with other conditions (e.g. infections, cerebral hemorrhage). MDA satisfactorily amplified viral DNA in the absence of human nucleic acids, but showed poor amplification capacity for viral DNA in CSF samples, and did not increase the sensitivity for herpes virus-detection with our methodology. CONCLUSIONS: Viral pathogens are rarely detected in CSF from patients without signs of CNS infection, supporting the view that real-time PCR is a highly specific method to detect symptomatic CNS-infection caused by these viruses. However, EBV may be subclinically reactivated due to other pathological conditions in the CNS.


Subject(s)
Central Nervous System Viral Diseases/diagnosis , Cerebrospinal Fluid/virology , Herpesviridae/classification , Herpesviridae/isolation & purification , Molecular Diagnostic Techniques/methods , Real-Time Polymerase Chain Reaction/methods , Virology/methods , Adolescent , Adult , Aged , Aged, 80 and over , Asymptomatic Diseases , Child , Child, Preschool , Female , Herpesviridae/genetics , Humans , Infant , Male , Middle Aged , Sensitivity and Specificity , Young Adult
3.
BMC Infect Dis ; 11: 223, 2011 Aug 19.
Article in English | MEDLINE | ID: mdl-21854593

ABSTRACT

BACKGROUND: The primary objective of this study was to investigate if extended antibiotic treatment against bacterial vaginosis (BV) together with adjuvant lactobacilli treatment could cure BV and, furthermore, to investigate factors that could cause relapse. METHODS: In all, 63 consecutive women with bacterial vaginosis diagnosed by Amsel criteria were offered a much more aggressive treatment of BV than used in normal clinical practice with repeated antibiotic treatment with clindamycin and metronidazole together with vaginal gelatine capsules containing different strains of lactobacilli both newly characterised and a commercial one (109 freeze-dried bacteria per capsule). Oral clindamycin treatment was also given to the patient's sexual partner. RESULTS: The cure rate was 74.6% after 6 months. The patients were then followed as long as possible or until a relapse. The cure rate was 65.1% at 12 months and 55.6% after 24 months. There was no significant difference in cure rate depending on which Lactobacillus strains were given to the women or if the women were colonised by lactobacilli. The most striking factor was a new sex partner during the follow up period where the Odds Ratio of having a relapse was 9.3 (2.8-31.2) if the patients had a new sex partner during the observation period. CONCLUSIONS: The study shows that aggressive treatment of the patient with antibiotics combined with specific Lactobacillus strain administration and partner treatment can provide long lasting cure. A striking result of our study is that change of partner is strongly associated with relapse of BV. TRIAL REGISTRATION: ClinicalTrials.gov: NCT01245322.


Subject(s)
Anti-Infective Agents/administration & dosage , Lactobacillus/growth & development , Probiotics/administration & dosage , Vaginosis, Bacterial/drug therapy , Adult , Clindamycin/administration & dosage , Female , Humans , Metronidazole/administration & dosage , Middle Aged , Secondary Prevention , Treatment Outcome
4.
APMIS ; 119(6): 373-6, 2011 Jun.
Article in English | MEDLINE | ID: mdl-21569095

ABSTRACT

Since bacterial vaginosis (BV) is characterized by a lack of, or very few, lactobacilli and high numbers of small, mostly anaerobic bacteria, an obvious treatment modality would be eradication of the BV-associated bacterial flora followed by reintroduction of lactobacilli vaginally. As probiotic treatment with lactobacilli is one tool for improving the cure rate when treating BV, it is necessary to know the length of time after treatment that clindamycin can be found in the vagina and if this could interfere with the growth of the probiotic lactobacilli. We evaluated the vaginal concentration of clindamycin in 12 women for 8 days to obtain data on the concentration of clindamycin in the vagina after intravaginal treatment with the drug. The participants were examined five times between two menstrual periods: before treatment, the day after treatment was finished, and 3, 5 and 8 days post-treatment. The first day post-treatment clindamycin 0.46 × 10(-3) to 8.4 × 10(-3) g/g vaginal fluid (median 2.87 × 10(-3)) was found. Thereafter, the concentration of clindamycin decreased rapidly. In 10 patients clindamycin was found after 3 days. A very low concentration was still present 5 days after treatment in four patients. After 8 days no clindamycin was found. Clindamycin is rapidly eliminated from the vagina, within 3-8 days, after local administration. Our results indicate that treatment with probiotic lactobacilli could be problematic if carried out within 5 days after cessation of clindamycin treatment.


Subject(s)
Anti-Bacterial Agents/administration & dosage , Clindamycin/pharmacokinetics , Vagina/microbiology , Vagina/pathology , Vaginosis, Bacterial/drug therapy , Administration, Intravaginal , Adult , Clindamycin/administration & dosage , Drug Therapy, Combination , Female , Humans , Lactobacillus/growth & development , Lactobacillus/metabolism , Middle Aged , Probiotics/administration & dosage , Prospective Studies , Treatment Outcome , Vaginosis, Bacterial/microbiology
5.
Clin Chem Lab Med ; 48(11): 1553-66, 2010 Nov.
Article in English | MEDLINE | ID: mdl-21062227

ABSTRACT

Scientists of disciplines in clinical laboratory sciences have long recognized the need for a common language for efficient and safe request of investigations, reporting of results, and communication of experience and scientific achievements. Widening the scope, most scientific disciplines, not only clinical laboratory sciences, rely to some extent on various nominal examinations, in addition to measurements. The 'International vocabulary of metrology--Basic and general concepts and associated terms' (VIM) is designed for metrology, science of measurement. The aim of the proposed vocabulary is to suggest definitions and explanations of concepts and terms related to nominal properties, i.e., properties that can be compared for identity with other properties of the same kind-of-property, but that have no magnitude.


Subject(s)
Clinical Laboratory Techniques , Terminology as Topic , Humans
6.
APMIS ; 118(11): 903-8, 2010 Nov.
Article in English | MEDLINE | ID: mdl-20955464

ABSTRACT

The aim of the study was to describe the prevalence and age distribution of bacterial vaginosis (BV) during an observation period of 15 years in a population study with cross-sectional samples of adult women living on the Åland Islands. The Åland Islands form an archipelago in the Baltic Sea and are a province of Finland. Every fifth year, specific age groups in the adult female population are invited to participate in a screening program for early diagnosis of cervical cancer using a papanicolaou (PAP)-stained vaginal smear. Women in the age groups of 20, 25, 30, 35, 40, 45, 50, 55, and 60 years are called each year. BV diagnosis of the PAP-stained smears uses the classification according to Nugent. The PAP-stained smears from the screening program of cervical cancer 1993, 1998, 2003, and 2008 were used in this study. A total of 3456 slides were investigated and 271 women could be followed for the 15-year observation period. The prevalence of BV declined from 15.6% in 1993 to 8.6% in 2008. The highest prevalence occurred among the age groups of 35 and 50 years. Among the 271 women who could be followed for the 15-year observation period, two-third showed normal/intermediate flora and one-third were infected with BV at least once. As this is a cross-sectional population study spanning 15 years, the prevalence of BV in the female adult population of the Åland Islands can be estimated. The prevalence has declined between 1993 and 2008 from 15.6% to 8.6%.


Subject(s)
Vaginosis, Bacterial/epidemiology , Adult , Age Distribution , Cross-Sectional Studies , Female , Finland/epidemiology , Geography , Humans , Middle Aged , Prevalence , Retrospective Studies , Vaginosis, Bacterial/diagnosis , Vaginosis, Bacterial/microbiology , Young Adult
8.
Stud Health Technol Inform ; 150: 265-9, 2009.
Article in English | MEDLINE | ID: mdl-19745311

ABSTRACT

In health care services, technology requires that correct information be duly available to professionals, citizens and authorities, worldwide. Thus, clinical laboratory sciences require standardized electronic exchanges for results of laboratory examinations. The NPU (Nomenclature, Properties and Units) coding system provides a terminology for identification of result values (property values). It is structured according to BIPM, ISO, IUPAC and IFCC recommendations. It uses standard terms for established concepts and structured definitions describing: which part of the universe is examined, which component of relevance in that part, which kind-of-property is relevant. Unit and specifications can be added where relevant [System(spec)-Component(spec); kind-of-property(spec) = ? unit]. The English version of this terminology is freely accessible at http://dior.imt.liu.se/cnpu/ and http://www.labterm.dk, directly or through the IFCC and IUPAC websites. It has been nationally used for more than 10 years in Denmark and Sweden and has been translated into 6 other languages. The NPU coding system provides a terminology for dedicated kinds-of-property following the international recommendations. It fits well in the health network and is freely accessible. Clinical laboratory professionals worldwide will find many advantages in using the NPU coding system, notably with regards to an accreditation process.


Subject(s)
Clinical Laboratory Information Systems , Forms and Records Control , Information Dissemination , Terminology as Topic , Access to Information , Europe , Female , Humans , Male , Medical Records Systems, Computerized
10.
Scand J Clin Lab Invest ; 68(4): 312-6, 2008.
Article in English | MEDLINE | ID: mdl-18609088

ABSTRACT

The reliability of interpretations of findings from dip-slide devices for culturing urine was investigated in a national Swedish external quality assessment (EQA) programme. Also investigated was the extent of improvement in the examination procedure achieved through personnel training programmes and information. According to Swedish national recommendations, dip-slide should only be used in primary health care (PHC) in cases of uncomplicated urinary tract infection (UTI) in females of childbearing age. The recommendations also define six possible outcomes of a dip-slide examination, outcomes that have formed the basis for the EQA programme since 2001. No improvement in ability to classify readings correctly into the six categories was noted for the period 2001 to 2006. Preparations containing 'mixed flora' presented participants with the greatest difficulty, with only 28 % correct reports. The EQA programme, with educational components and voluntary participation, has not improved quality. The disappointing results might be a reflection of the limited effort and resources allocated by clinical microbiology laboratories for training and for sustaining proficiency in the evaluation of dip-slides. For these reasons, we cannot at present recommend the dip-slide technique for use in PHC settings.


Subject(s)
Bacteriological Techniques/instrumentation , Medical Staff , Primary Health Care , Urine/microbiology , Female , Health Care Surveys , Humans , Sweden , Urinary Tract Infections/diagnosis , Urinary Tract Infections/microbiology , Workforce
11.
Ann Clin Microbiol Antimicrob ; 7: 14, 2008 Jun 30.
Article in English | MEDLINE | ID: mdl-18590533

ABSTRACT

BACKGROUND: Signature matching of nucleotide sequences in the V1 and V3 regions 16S rRNA genes using pyrosequencing technology is a powerful tool for typing vaginal Lactobacilli to the species level and has been used for investigating the vaginal microbial niche. METHODS: This study has characterized the normal cultivable vaginal Lactobacillus flora at varying estradiol levels in plasma; the study comprised 17 patients undergoing ovarian stimulation for In Vitro Fertilization (IVF) treatment. The vaginal status of each participant was initially assessed as normal according to Amsel and Nugent criteria. RESULTS: L. crispatus, L. gasseri and/or L. jensenii were present in 10 of the patients throughout the study period, and little variation among these three species was encountered in individual patients. The flora of three women was dominated by L. delbrüeckii, L. rhamnosus or L. vaginalis. One woman exhibited a dominance of L. iners. The flora of the remaining three women were initially dominated by L. rhamnosus or L. reuteri, but as their estrogen levels rose, their flora composition altered, to become dominated by one of the three species most common in a normal, healthy vagina. CONCLUSION: Signature matching of nucleotide sequences in the V1 and V3 regions of 16S rRNA genes is a discriminative tool for the study of vaginal Lactobacilli and can be used to track the Lactobacillus flora under a variety of physiological conditions.


Subject(s)
Fertilization in Vitro , Lactobacillus/isolation & purification , Vagina/microbiology , Bacterial Proteins/genetics , Bacterial Typing Techniques , Base Sequence , DNA, Bacterial/genetics , DNA, Ribosomal/genetics , Female , Humans , Lactobacillus/genetics , Molecular Sequence Data , Polymerase Chain Reaction , RNA, Ribosomal, 16S/genetics
12.
BMC Womens Health ; 7: 20, 2007 Oct 22.
Article in English | MEDLINE | ID: mdl-17953762

ABSTRACT

BACKGROUND: Bacterial vaginosis (BV) during pregnancy is associated with an increased risk of preterm delivery but little is known about factors that could predict BV. We have analyzed if it is possible to identify a category of pregnant women that should be screened for BV, and if BV would alter the pregnancy outcome at term; we have also studied the treatment efficacy of clindamycin. METHODS: Prospective BV screening and treatment study of 9025 women in a geographically defined region in southeast Sweden. BV was defined as a modified Nugent score of 6 and above. Data was collected from the Swedish Medical Birth Register. Women allocated to treatment were supplied with vaginal clindamycin cream. The main outcome goals were to identify factors that could predict BV. RESULTS: Vaginal smears were consistent with BV criteria in 9.3%. Logistic regression indicates a significant correlation between smoking and BV (p < 0.001) and a greater prevalence of BV in the lower age groups (p < 0.001). We found no correlation between BV and history of preterm deliveries, previous miscarriages, extra-uterine pregnancies, infertility problems or reported history of urinary tract infections-factors that earlier have been associated with BV. Treatment with clindamycin cream showed a cure rate of 77%. Less than 1% of women with a normal vaginal smear in early pregnancy will develop BV during the pregnancy. There was no association between BV and the obstetric outcome among women who delivered at term. Women with BV, both treated patients and nontreated, had the same obstetric outcome at term as women with normal vaginal flora. CONCLUSION: BV is more than twice as common among smokers, and there is a higher prevalence in the younger age group. However these two markers for BV do not suffice as a tool for screening, and considering the lack of other risk factors associated with BV, screening of all pregnant women might be a strategy to follow in a program intended to reduce the number of preterm births.


Subject(s)
Clindamycin/administration & dosage , Pregnancy Complications, Infectious/drug therapy , Pregnancy Complications, Infectious/epidemiology , Pregnancy Outcome/epidemiology , Vaginosis, Bacterial/drug therapy , Vaginosis, Bacterial/epidemiology , Adult , Anti-Bacterial Agents/administration & dosage , Female , Humans , Logistic Models , Mass Screening/statistics & numerical data , Obstetric Labor, Premature/epidemiology , Pregnancy , Prevalence , Prospective Studies , Risk Factors , Sweden/epidemiology , Treatment Outcome , Vaginal Creams, Foams, and Jellies/administration & dosage , Vaginal Smears/statistics & numerical data
17.
Lakartidningen ; 102(17): 1308-9, 1311-2, 1314-5, 2005.
Article in Swedish | MEDLINE | ID: mdl-15921106

ABSTRACT

When communicating results from laboratory investigations from the laboratory to the requesters and further between different information systems, it is important that the value as well as the unique identity and name of the laboratory investigation are correctly cited. A committee under the International Federation for Clinical Chemistry and Laboratory Medicine (IFCC) and International Union for Pure and Applied Chemistry (IUPAC) has developed a systematic nomenclature for the correct classification of laboratory investigations. Each generic laboratory investigation is provided with a unique NPU code. The system is in use among approximately 30 different clinical laboratories in Sweden, and has capacity to be the common denominator of all laboratory investigations, and to be used as the identifier in various information systems. The NPU system for the Swedish laboratories is currently administered by EQUALIS and partly financed by the participating laboratories. Other ways of funding, of benefit for the whole health care sector, will be investigated.


Subject(s)
Chemistry, Clinical , Clinical Laboratory Information Systems , Concept Formation , Terminology as Topic , Chemistry, Clinical/classification , Chemistry, Clinical/standards , Clinical Laboratory Information Systems/classification , Clinical Laboratory Information Systems/standards , Humans , Vocabulary, Controlled , Weights and Measures
19.
Acta Derm Venereol ; 85(1): 42-6, 2005.
Article in English | MEDLINE | ID: mdl-15848990

ABSTRACT

The expected 4-week cure rate after conventional treatment of bacterial vaginosis are only 65-70%. In an attempt to improve the cure rate by adding probiotic lactobacilli we performed a double-blind placebo-controlled study of adjuvant lactobacilli treatment after an open treatment with vaginal clindamycin ovules. Women with bacterial vaginosis as defined by Amsel's criteria were treated with clindamycin ovules. Vaginal smears were collected and analysed according to Nugent's criteria. During the following menstruation period the women used, as an adjuvant treatment, either lactobacilli-prepared tampons or placebo tampons. The lactobacilli tampons were loaded with a mixture of freeze-dried L. fermentum, L. casei var. rhamnosus and L. gasseri. The cure rate was recorded after the second menstruation period. There was no improvement in the cure rate after treatment with lactobacilli-containing tampons compared to placebo tampons; the cure rates as defined by Amsel's criteria were 56% and 62%, respectively, and 55% and 63%, as defined by Nugent's criteria. This is the first study to report cure rates for women with 'intermediate' wet smear ratings according to Nugent's classification and this group had an overall cure rate of 44%. The cure rate of treatment of bacterial vaginosis was not improved by using lactobacilli-prepared tampons for one menstruation.


Subject(s)
Anti-Bacterial Agents/therapeutic use , Clindamycin/therapeutic use , Lactobacillus , Probiotics/therapeutic use , Vaginosis, Bacterial/therapy , Administration, Intravaginal , Adolescent , Adult , Double-Blind Method , Female , Humans , Menstrual Hygiene Products/microbiology , Middle Aged , Treatment Outcome , Vaginal Smears
20.
APMIS ; 113(3): 153-61, 2005 Mar.
Article in English | MEDLINE | ID: mdl-15799757

ABSTRACT

Diagnosing bacterial vaginosis (BV) has long been based on the clinical criteria of Amsel et al., whereby three of four defined criteria must be satisfied. Though there are other criteria and scoring methods which function well in comparison (i.e. Nugent scoring), it is not certain that they will always identify the same category of patients. Point-of-care methods based on various combinations of microbial products, presence of RNA, or more complex laboratory instrumentations such as sensor arrays, have also been introduced for the diagnosis of BV. No method for diagnosing BV can at present be regarded as the best. It could be that--based partly on tacit knowledge on the part of the clinical investigators scoring in the clinic--various scoring systems have been chosen to fit a particular BV-related problem in a particular population. In this review we critically examine these pertinent issues influencing clinical scoring and laboratory diagnostics of BV.


Subject(s)
Vaginosis, Bacterial/diagnosis , Clinical Laboratory Techniques , Female , Humans , Vaginosis, Bacterial/epidemiology , Vaginosis, Bacterial/microbiology
SELECTION OF CITATIONS
SEARCH DETAIL